A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer
Clinical trial NCT00762034 · COMPLETED
Trial details
- NCT number
- NCT00762034
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2012-04-01
- Enrollment
- 939
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.